Because so little of the oral dose survives digestion even with SNAC, the tablet needs a 25 mg dose to deliver an equivalent effect to the 2.4 mg weekly injection
Discussion Due to the central roles exerted by the three metabolically related peptide hormone receptors (GIPR, GLP-1R and GCGR) in the management of T2DM and obesity, the concept of combinatorial agonism or polypharmacology to synergize metabolic actions and maximize therapeutic benefits has been explored in the past decade with remarkable preclinical and clinical achievements
The next to come down the track is tirzepatide (Eli Lilly), which studies suggest has an even more impressive impact on weight loss[6]
Nausea affects approximately 28% of users at the highest dose, with rates lower at reduced amounts
Example: 5mg per injection
Common GLP-1 medications available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia)